SCHEMBL16659306

SCHEMBL16659306

CC1(C)c2cc(-c3ccccc3)ccc2-c2ccc(-c3cnc(-n4c5ccccc5c5ccc(-c6ccc7c(c6)c6ccccc6n7-c6ccccc6)cc54)nc3)cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ TSPO P30536 1/20 0.33
▸ RXRA P19793 1/20 0.32
▸ RXRB P28702 1/20 0.32
▸ PTGER4 P35408 1/20 0.32
▸ AVPR1A P37288 1/20 0.31
▸ HDAC4 P56524 1/20 0.31
▸ NPC1 O15118 1/20 0.30
▸ POLB P06746 1/20 0.30
▸ GAA P10253 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ RXFP1 Q9HBX9 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30
▸ RAC2 P15153 1/20 0.30
▸ RAC3 P60763 1/20 0.30
▸ CDC42 P60953 1/20 0.30
▸ RAC1 P63000 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16659295 1.00 KDM4E (0.36) KDM4EATML3MBTL1TSPORXRA
SCHEMBL15626482 0.97 KDM4E (0.38) KDM4EATML3MBTL1TSPOPTGER4
SCHEMBL15358330 0.96 KDM4E (0.35) KDM4EATML3MBTL1TSPORXRA
SCHEMBL15626487 0.93 KDM4E (0.37) KDM4EATML3MBTL1TSPOPTGER4
SCHEMBL16659261 0.90 TSPO (0.31) TSPORXRARXRB
SCHEMBL16659268 0.90 TSPO (0.31) TSPORXRARXRB
SCHEMBL15358289 0.89 KDM4E (0.35) KDM4EATML3MBTL1TSPORXRA
SCHEMBL24490406 0.89 KDM4E (0.37) KDM4EATML3MBTL1
SCHEMBL15358272 0.88 L3MBTL1 (0.46) KDM4EATML3MBTL1TSPORXRA
SCHEMBL16659312 0.88 L3MBTL1 (0.46) KDM4EATML3MBTL1TSPORXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150112064-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ROHM & HAAS ELECT MAT (KR) 2015-04-23 — — US disclosed
US-20150112064-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ROHM & HAAS ELECT MAT (KR) 2015-04-23 — — US disclosed
US-20140012032-A1 METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS PIRAMAL IMAGING SA (CH) 2014-01-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140012032-A1 METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS APP, APBA1, BACE1 KDM4E 4670/4885ATM 4465/4885L3MBTL1 3938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback